151 related articles for article (PubMed ID: 17967574)
1. The use of B-type natriuretic peptide to assess volume status in dialysis patients.
Codognotto M; Piccoli A
Am Heart J; 2007 Nov; 154(5):e31. PubMed ID: 17967574
[No Abstract] [Full Text] [Related]
2. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide and impedance cardiography to assess volume status in peritoneal dialysis patients.
Granja CA; Tailor PT; Gorban-Brennan N; Francis J; Bekui A; Finkelstein FO
Adv Perit Dial; 2007; 23():155-60. PubMed ID: 17886624
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure.
Mark PB; Petrie CJ; Jardine AG
Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
[TBL] [Abstract][Full Text] [Related]
7. Are levels of brain natriuretic peptides useful to determine volume status in dialysis patients?
Vukelic V; Peixoto AJ
Semin Dial; 2011; 24(4):400-2. PubMed ID: 21851400
[No Abstract] [Full Text] [Related]
8. Brain natriuretic peptide variations are linked to volume status in hemodialysis patients.
Roueff S; Martin E; Chauffert ML; Poli I; Kihal K; Yazbeck F; Abbassi A; Saint-Georges M
Clin Nephrol; 2008 Dec; 70(6):508-13. PubMed ID: 19049708
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of continuous blood volume monitoring.
Lopot F
EDTNA ERCA J; 1996; 22(4):7-11. PubMed ID: 10723339
[TBL] [Abstract][Full Text] [Related]
10. [Evidence for the existence of a positive feedback of the degree of expansion of the circulating volume, atrial distension and atrial natriuretic peptide in dialyzed uremic patients].
Cannella G; Assanelli D; Ghielmi S; Gaggiotti M; Sandrini M; Poiesi C; Cuminetti S; Chiari E; Maiorca R
Ann Ital Med Int; 1988; 3(2):103-10. PubMed ID: 2978954
[No Abstract] [Full Text] [Related]
11. B-type natriuretic peptide in end-stage renal disease: a neurohormone rather than a volume status monitor.
Maeder MT; Kaye DM
South Med J; 2008 Nov; 101(11):1081-2. PubMed ID: 19088508
[No Abstract] [Full Text] [Related]
12. Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients.
Toussaint ND; Polkinghorne KR; Kerr PG
Hemodial Int; 2008 Apr; 12(2):254-63. PubMed ID: 18394060
[TBL] [Abstract][Full Text] [Related]
13. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
[TBL] [Abstract][Full Text] [Related]
14. [Dependence between blood pressure, blood volume and body weight in patients with kidney insufficiency].
Braun L; Krasemann PH; Michalke HJ
Z Kreislaufforsch; 1968 Dec; 57(12):1190-8. PubMed ID: 5710020
[No Abstract] [Full Text] [Related]
15. Strict volume control and longitudinal changes in cardiac biomarker levels in hemodialysis patients.
Ortega O; Rodriguez I; Gracia C; Sanchez M; Lentisco C; Mon C; Gallar P; Ortiz M; Herrero JC; Oliet A; Vigil A
Nephron Clin Pract; 2009; 113(2):c96-103. PubMed ID: 19602905
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides in ESRD.
Joffy S; Rosner MH
Am J Kidney Dis; 2005 Jul; 46(1):1-10. PubMed ID: 15983951
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with cardiorenal anemia syndrome.
Leszek P; Kruszewski M
Am Heart J; 2008 Mar; 155(3):e25; author reply e19. PubMed ID: 18294469
[No Abstract] [Full Text] [Related]
18. Peculiar blood volume profile during hemodiafiltration therapy: of benefit to the hemodynamic stability in patients?
Kawabata M; Kasuga S; Ogawa T; Suyama S; Moriyama K; Takabatake T
Clin Nephrol; 1998 Nov; 50(5):333-4. PubMed ID: 9840324
[No Abstract] [Full Text] [Related]
19. [Natriuretic peptides, renal impairment and onset of cardiovascular complications].
Pudil R; Tichý M
Vnitr Lek; 2009 Oct; 55(10):913-4. PubMed ID: 19947232
[No Abstract] [Full Text] [Related]
20. [Hemofiltration in patients with chronic renal failure (author's transl)].
Morales J; Fuentes P; James E; Zehnder C; de Halleux C; Thielemann I; Andaur V; Artigas G; Saavedra B; Morales I; Pérez E
Rev Med Chil; 1978 Jul; 106(7):511-4. PubMed ID: 694275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
